Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, July 13, 2024 | Back issues
Courthouse News Service Courthouse News Service

Birth Defects

OAKLAND, Calif. - GlaxoSmithKline pushed its drug Zofran, approved to fight side effects of chemotherapy, for off-label treatment of morning sickness, and a woman's baby was born with "devastating" heart defects because of it, she claims in Alameda County Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.